MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0194305
Apt Testing and Research Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.4 Cr
▲ 39% YoY
Net loss · FY 2025
₹7.61 Lakh
Net margin -5.4%
EBITDA · FY 2025
₹36.6 Lakh
EBITDA margin 26.2%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Satisfied charges
₹60 Lakh
No open charges
Company age
18 yrs
Est. 2008
Employees · EPFO
21
Provident fund records
About Apt Testing and Research Private Limited
Data last updated:
Apt Testing and Research Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 16 May 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74220PN2008PTC132043. Its GSTIN is 27AAHCA0527A1ZB (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Renu Singh Mokashi and Kishori Ganpat Apte.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S N – 36/1/1 M. N – 199 Vadagaon Khurd Pune, Maharashtra, India – 411041.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.4 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net loss of ₹7.61 Lakh (net margin -5.4%) and EBITDA of ₹36.6 Lakh (EBITDA margin 26.2%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years and 2% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹60 Lakh on record. The company has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹37.3 Lakh; the latest was in October 2020. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Calibre Pharmaceutical Private Limited with revenue of ₹1.47 Cr.
Apt Testing and Research Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0194305). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ntc-apt.com.
Company Details of Apt Testing and Research Private Limited
CIN U74220PN2008PTC132043
Registration Number 132043
Incorporation Date 16 May 2008
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0194305
Recognitions & Rankings of Apt Testing and Research
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressS N – 36/1/1 M. N – 199 Vadagaon Khurd Pune, Maharashtra, India – 411041
- IndustryPharma, Pharma Contract R&D
Comprehensive company report
Apt Testing and Research Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Apt Testing and Research Private Limited
The main business activity of Apt Testing and Research is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Apt Testing and Research Private Limited FY 2025 filings available
Apt Testing and Research Private Limited reported revenue of ₹1.4 Cr (up 39% YoY) for FY 2025.
Revenue · FY 2025
₹1.4 Cr ▲ 39%
Net loss · FY 2025
₹7.61 Lakh margin -5.4%
EBITDA · FY 2025
₹36.6 Lakh margin 26.2%
Compounded Annual Growth Rate (CAGR) of Apt Testing and Research Private Limited
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 13%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 190%
3 years · compounded
▲ 37%
5 years · compounded
▲ 41%
Revenue rose 39% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 190% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Apt Testing and Research Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹36.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹7.61 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Apt Testing and Research Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -5.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Apt Testing and Research are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Apt Testing and Research Private Limited
Apt Testing and Research has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renu Singh Mokashi | Director | 23 Jun 2023 | 3 Years 3 Months | Current |
| Kishori Ganpat Apte | Director | 16 May 2008 | 18 Years 5 Months | Current |
Peer Comparison of Apt Testing and Research Private Limited
Apt Testing and Research Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Calibre Pharmaceutical Private Limited | ₹1.47 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Uttar Pradesh, India |
| Kreative Actives Private Limited | ₹1.45 Cr (FY 2023) | •••• | •••• | 14755.0% | •••• | Hyderabad, Telangana, India |
| Relez Pharma Private Limited | ₹1.44 Cr (FY 2025) | •••• | •••• | 71.0% | •••• | Surat, Gujarat, India |
| Evgenis Pharma Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Mumbai, Maharashtra, India |
| Baebies Diagnostics India Private Limited | ₹1.42 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Hyderabad, Telangana, India |
| Apt Testing and Research Private Limited this company | ₹1.4 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Pune, Maharashtra, India |
| Chromatogen Analytical Solutions (OPC) Private Limited | ₹1.39 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Mysore, Karnataka, India |
| Abbess Health Care OPC Private Limited | ₹1.39 Cr (FY 2025) | •••• | •••• | -50.0% | •••• | Navi Mumbai, Maharashtra, India |
| Bioinnovat Research Services Private Limited | ₹1.38 Cr (FY 2025) | •••• | •••• | -49.0% | •••• | New Delhi, Delhi, India |
| GRK Research Laboratories Private Limited | ₹1.37 Cr (FY 2024) | •••• | •••• | -30.0% | •••• | Hyderabad, Telangana, India |
| Chemtrack Lifesciences Private Limited | ₹1.36 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Apt Testing and Research by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Apt Testing and Research Private Limited
Apt Testing and Research Private Limited is audited by Mehra Amit & Co for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Mehra Amit & Co | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Apt Testing and Research Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Apt Testing and Research Private Limited
Open charges
None
Satisfied charges
₹60 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2020 | Others | ₹60 Lakh | Satisfied |
Total charge records: 1 View all charges
Deals & Funding of Apt Testing and Research Private Limited
Apt Testing and Research Private Limited has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹37.3 Lakh; the latest was in October 2020.
Total deals
3
Rights issue
1
Funding round
1
Secondary share transfer
1
Disclosed funding
₹37.3 Lakh
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2016 | Funding round | ₹37.3 Lakh | Investors: an individual |
| Mar 2016 | Rights issue | ₹61.7 Lakh | Investors: 3 individuals |
Premium access
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Apt Testing and Research Private Limited
Apt Testing and Research Private Limited has a workforce of 21 employees as of Mar 28, 2024.
Employee count
21
Active EPFO establishments
1
Employee growth
-4.55%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Apt Testing and Research Private Limited
Apt Testing and Research Private Limited has 8 board changes on record since 2008: 2 appointments and 6 cessations. The latest: Sagar Vishnu Jog ceased to be Additional Director on 25 Jul 2023.
AGM
Apt Testing And Research Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Apt Testing And Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Sagar Vishnu Jog ceased to be Additional Director.
Appointed
Renu Singh Mokashi was appointed as Director.
Charges
A charge registered on 07 Sep 2020 via Charge ID 100370095 with Others was fully satisfied on 09 Feb 2023.
Charges
A charge with Others amounted to Rs. 0.60 Cr with Charge ID 100370095 was registered on 07 Sep 2020.
Ceased
Tejas Shah ceased to be Director.
Ceased
Amol Nimba More ceased to be Additional Director.
Ceased
Usha Ganpat Apte ceased to be Director.
Ceased
Ravindra Purushottam Joshi ceased to be Additional Director.
Ceased
Ashok Wagadarikar ceased to be Director.
Appointed
Kishori Ganpat Apte was appointed as Director.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Apt Testing and Research Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apt Testing and Research Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apt Testing and Research Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Apt Testing and Research Private Limited
Apt Testing and Research has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCA0527A1ZB | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apt Testing and Research Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apt Testing and Research Private Limited
Apt Testing and Research is an active private limited company based in Pune, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 16 May 2008 (18+ years old) and is registered under CIN U74220PN2008PTC132043.
Apt Testing and Research reported revenue of ₹1.4 Cr for FY 2025 (up 39% YoY).
Apt Testing and Research has 2 current directors:
- Renu Singh Mokashi - Director
- Kishori Ganpat Apte - Director
Apt Testing and Research reported a net loss of ₹7.61 Lakh (net margin -5.4%) and EBITDA of ₹36.6 Lakh (EBITDA margin 26.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Apt Testing and Research is 13% over three years and -2% over five years. In the latest year (FY 2025) revenue rose 39%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Apt Testing and Research is 27AAHCA0527A1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Apt Testing and Research is U74220PN2008PTC132043. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apt Testing and Research was incorporated on 16 May 2008, making it 18+ years old. It is registered with the Registrar of Companies, Pune.
Apt Testing and Research has 3 deals on record (1 rights issue, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹37.3 Lakh; the latest was in October 2020.
The peers of Apt Testing and Research by revenue are Calibre Pharmaceutical Private Limited, Kreative Actives Private Limited, Relez Pharma Private Limited, Evgenis Pharma Private Limited, Baebies Diagnostics India Private Limited and 5 more, all in the Pharma industry (Contract Research).
Sagar Vishnu Jog ceased to be Additional Director on 25 Jul 2023. Renu Singh Mokashi was appointed as Director on 23 Jun 2023. Tejas Shah ceased to be Director on 20 Jan 2020. Apt Testing and Research has 8 board changes on record in total.